Net Cash Provided by (Used in) Financing Activities of CalciMedica, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CalciMedica, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • CalciMedica, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $10,742,000, a 44% decline year-over-year.
  • CalciMedica, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $15,212,000, a 46% decline from 2024.
  • CalciMedica, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $27,974,000, a 34% increase from 2023.
  • CalciMedica, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $20,900,000, a 147% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

CalciMedica, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $15,212,000 -$12,762,000 -46% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $27,974,000 +$7,074,000 +34% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $20,900,000 +$12,424,000 +147% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $8,476,000 +$7,781,000 +1120% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $695,000 -$91,477,000 -99% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $92,172,000 +$37,301,000 +68% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022 2021 FY
2019 $54,871,000 01 Jan 2019 31 Dec 2019 10-K 05 Mar 2021 2020 FY

CalciMedica, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $10,742,000 -$8,301,000 -44% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $19,043,000 -$4,472,000 -19% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $23,515,000 +$23,514,000 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $1,000* -$91,000 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $92,000 +$932,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $840,000 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.